Chemical genetic screening can be described as a discovery approach in which chemicals are assayed for their effects on a defined biological system. The zebrafish, Danio rerio, is a well-characterized and genetically tractable vertebrate model organism that produces large numbers of rapidly developing embryos that develop externally. These characteristics allow for flexible, rapid and scalable chemical screen design using the zebrafish. We describe a protocol for screening compounds from a chemical library for effects on early zebrafish development using an automated in situ based read-out. As screenings are carried out in the context of a complete, developing organism, this approach allows for a more comprehensive analysis of the range of a chemical's effects than that provided by, for example, a cell culture-based or in vitro biochemical assay. Using a 24-h chemical treatment, one can complete a round of screening in 6 d.
INTRODUCTION
The modern biologist's toolbox continues to expand with an array of techniques aimed at dissecting the basic processes of development and disease. The continually refined approaches of molecular genetics allow for gain-and loss-of-function of a target gene(s), often with a degree of temporal and spatial control (for reviews, see refs. 1,2). Yet in the absence of gene therapy approaches, these techniques are not immediately transferable to therapeutic applications. Although the precision of a targeted gene deletion may offer clear advantages for interpreting perturbations, the analysis may be confounded by functional redundancy (e.g., see refs. 3, 4) .
A chemical genetics approach in which exogenous, typically small molecules are assayed for their ability to alter a biological process-of-interest has proven complementary [5] [6] [7] [8] [9] (also, see Table 1 and references therein). Temporal control is easily achieved by adding a chemical at a chosen time-point. Once a given chemical treatment produces a relevant effect, this molecule can serve as a ready starting point for drug discovery 10 . A given chemical can have pleiotropic effects that may prove to be a boon in altering a multilayered process, but may indeed prove to be a burden when seeking to identify the key target or mechanism of action 11 .
Here we describe a framework for chemical genetic screening in the embryo of the zebrafish, Danio rerio, built on our laboratory's experience using this modality [12] [13] [14] . Zebrafish are small (100+ fish per 20-liter tank), reproduce rapidly (100's+ embryos per week per adult female) and develop quickly (most organs are formed within 24 h), thus offering the advantages of an in vivo high throughput, highly scalable system that is typically associated with cell culture. Biological processes can be assayed in the native context of a complete, developing organism that is transparent, develops externally and is genetically highly manipulable (for a review, see ref. 15 ).
In 2000, Peterson et al. 16 presented the initial developmental chemical genetic screen in zebrafish. 1,100 chemicals were assayed in wild-type embryos for their effects on the development of the central nervous system, the cardiovascular system, pigmentation and the ear. By visually examining embryos daily for 3 d, the authors identified chemicals that produced defects in each of these structures. This included, for example, compound 33N14 or (2-morpholinobutyl)-4-thiophenol (MoTP) which prevented pigmentation in the zebrafish body, and has since been used in studies of melanocyte biology 17, 18 .
Chemical genetic screening in the zebrafish has since been used to identify chemical suppressors of defined genetic mutations. In 2004, Peterson et al. screened 5,000 chemicals searching for compounds that suppress the aorta malformation phenotype in the grl mutant zebrafish caused by a mutation in the transcription factor hey2 (ref. 19) . By assaying for restoration of blood flow to the tail of 48-h post-fertilization mutant embryos following chemical treatment, the authors identified two compounds, GS3999 and GS4102, that upregulated vascular endothelial growth factor (VEGF) expression and resulted in restoration of blood flow. Soon after, we reported a screening of 16,320 compounds aimed at identifying suppressors of the cell cycle mutant crb that results from a mutation in the bmyb oncogene 12 . A new compound, termed persynthamide, was identified that suppressed the mitotic accumulation phenotype of crb as judged by whole-mount immunohistochemical staining for serine-10 phosphorylated histone H3.
Two more recent reports highlight the use of in situ hybridization (ISH) as a read-out for a chemical genetic screen. In order to identify regulators of hematopoietic stem cell (HSC) formation and homeostasis, we 14 screened B2,500 compounds for their ability to alter HSC numbers during embryogenesis in the zebrafish as judged by in situ of HSC markers runx1 and cmyb. In all, ten compounds that affect the prostaglandin pathway were identified with enhancement or suppression of the prostaglandin pathway increasing or decreasing HSC's, respectively (see Fig. 1a-c) . Follow-up work recently showed a critical interaction of prostaglandin signaling with Wnt pathway activation in the vertebrate HSC compartment 20 . Finally, Yeh et al. 21 recently used an in situbased approach to screen a library of 2,000 bioactive compounds for modulators of an oncogene's effects on differentiation of hematopoietic progenitor cells. By leveraging the molecular genetics tools available in the zebrafish, the authors use a transgenic zebrafish with a heat shock inducible transgene for the AML1-ETO oncogene that when expressed in embryos causes a decrease in erythropoietic lineage cells (as read-out by decreased GATA-1 in situ) in favor of granulopoietic cells. Two compounds, dicumarol and nimesulide, restore GATA-1 expression, and the second is shown to also act through the prostaglandin and Wnt pathways.
Experimental design
In addition to the discussion above, we have highlighted the operational details of published chemical genetic screens in zebrafish ( Table 1) , and below introduce what we believe are some key considerations to be formally determined when embarking on a chemical screen. The procedure described herein outlines an approach for an in situ-based chemical screen in which embryos are treated with chemicals for B24 hours, but it can be easily modified to accommodate differing chemical treatment times and/ or read-outs. An overview of the protocol is shown in Figure 2 .
Aim of the screen. What developmental process are we hoping to alter? What pathway are we expecting to target? Previous screens have successfully broadly targeted the development of an entire organ system (e.g., the central nervous system 16 ) or more precisely aimed at affecting specific signaling molecules (e.g., the mitotic regulator bmyb 12 ).
Zebrafish: general husbandry, mating and embryo stages. Both simple pair matings and group matings (3 females and 2 males) can be used to generate embryos. Group matings will yield, on average, 200-500 embryos per lay but will lead to a wider distribution of embryo stages. Mixing embryos, which have a wide distribution of developmental stages, may confound later attempts at scoring for chemical effects, as a given chemical may only produce an effect during a narrow window of developmental time 16 . Familiarity with the staging of zebrafish embryos based on morphology will facilitate sorting of synchronized embryos 22 . Finally, antibiotics can be added at the discretion of the researcher, but for short assays as presented here, it is likely unnecessary.
Read-out. How will we identify putative 'hits' in our screen that affect the process of interest? In order to assay for the effects of possibly thousands of chemicals, a read-out should, ideally, not only accurately reflect a perturbation in the desired process but should also be rapid, reproducible, scalable and sensitive. Pros and cons of various read-out methods applied to date in the literature and/or our lab are described in Table 2 , along with theoretical concerns related to each. For example, visual examination of embryos for structural alterations following chemical treatment requires no reagent development, but may be limited in the range of structures that can be monitored. ISH allows for visualization of the expression of, in principle, any gene product but may require significant preliminary reagent development including cloning of the specified cDNA and optimization of the ISH protocol for the corresponding probe. The use of this method has been previously described by our laboratory in which alterations in in situ staining for runx1/cmyb corresponds to alterations in numbers of HSC's (see Fig. 1a -c) 14 .
Timing or duration of chemical exposure and toxicity. The time frame for chemical treatment should precede and, if possible, overlap with the interval during which the targeted process or pathway is active. In our experience, extended exposures to chemical treatment (i.e., 424 h) or treatment before 6-h post fertilization (i.e., roughly 50% epiboly 22 ) significantly increases the death rate of embryos as compared with negative control embryos. By noting the death rate of embryos in the negative control wells (typically limited to one, or at most two, out of ten embryos), one can ascertain that a given compound is toxic at the tested concentration, when the majority of embryos in the treated well are dead. Depending on the number of compounds being screened in a given round, one should consider examining for embryo death and (if time permits and it does not interfere with the timely processing of the embryos) for evidence of teratogenicity or developmental delay before pronase treatment and chorion removal ( Fig. 3a-c) . Dead embryos will appear opaque and can be identified quickly with minimal delay to the workflow (Fig. 3c) . It is important to note that these dead embryos will be removed during pronase treatment and subsequent washing, leaving an empty well. Toxic compounds should be retested at a lower dose in subsequent testing.
For read-outs that require embryos to develop to later developmental stages, consider adding a 'wash-out' step to remove chemicals if it is plausible that an effect produced by an early, transient chemical exposure will persist during embryonic development. for which some mechanistic information may already be available, should facilitate follow-up and molecular characterization of a chemical's effect, but may bias towards less novel mechanisms. In addition, pooling of chemicals has been used to decrease the number of individual observations which are needed to screen a library in its entirety 12 , but this may result in unpredictable interactions between multiple chemicals within a pool and has also led to an unacceptable level of embryo death.
Most commercially available libraries come in 384-well format with chemicals dissolved in 100% DMSO. A typical range of concentrations of these stock chemicals is 5-10 mM. In this protocol, 1 ml of stock solution is added to 100 ml of E3 medium and then added to embryos in 200 ml of E3 medium. This provides automatic mixing and avoids having to use pipettes to mix in the presence of embryos, which can be damaging to the embryos. The final volume of 300 ml corresponds to a concentration of chemical between 16-33 mM and a final concentration of DMSO of 0.3% (vol/vol).
Controls.
A negative control that contains the vehicle alone (e.g., DMSO) should be included on each plate. The vehicle can have biological effects unrelated to the chemical being screened, and inclusion of such a negative control allows for monitoring of embryo staging and for degree of in situ staining. Although not always available, a positive control(s) should be included as well. Ideally, this would be a chemical that produces the desired read-out in treated embryos, but the use of a morphant, for example, may provide a substitute.
Automation of ISH.
In situ hybridization of whole zebrafish embryos, as described by Thisse and Thisse 24 commonly used procedure. To carry out ISH on embryos that are still in their chorions (Bo48 hpf, hours post fertilization), the protease pronase is added to the embryos to soften the chorion and allow for chorion removal during subsequent wash steps. These wash steps also prevent overdigestion with pronase, which can damage embryos and lead to degradation during subsequent ISH steps. Removal of the chorion is necessary to allow the ISH reagents and washes to access the embryo. Once embryos have reached the desired stage, they are fixed in a 4% (wt/vol) PFA solution, optimally for one night or for 2-3 d before the quality of the ISH begins to diminish. Embryos are then dehydrated by adding methanol and can be stored at À20 1C in this state for months. Each in situ antisense probe for each gene of interest must be individually optimized. Traditionally, the 3¢ end of a gene including its 3¢ UTR is used to generate the antisense digoxigenin-labeled RNA probe used for ISH, although full-length cDNAs may be successfully used. A final probe concentration of 1 ng ml À1 serves as a good starting point for ISH, but lower probe concentrations may be sufficient for, for example, highly expressed genes. Finally, alkaline phosphatase conjugated anti-digoxigenin Fab antibody fragment is used for detection of the ISH probe via production of a purple precipitate (catalyzed by the alkaline phosphatase). In order to avoid formation of non-specific purple precipitates, it is important to allow for adequate equilibration in the appropriate alkaline (pH 9.5) Tris buffer before addition of the substrate reagent, as described below.
Use of an in situ robot, such as the Biolane HTI (see Equipment), allows for automation of the ISH protocol. We describe the use of 48-well flat bottom plates for chemical treatment and 48-well mesh bottom plates for the automated ISH. One robot can handle a total of four 48-well plates at a time. In our experience when using smaller format plates (e.g., 96-well plates), the death of one embryo in a well led to the death of all embryos in that well. In addition, liquid exchange in individual wells during the automated ISH protocol was less efficient (possibly related to the type of mesh bottom plates which were used). Using fewer embryos per well, different treatment schemes or alternate mesh bottom plates (e.g., MultiScreen Mesh, cat. no. MANM10010 (Millipore, Billerica, MA), which have recently become available again) may allow for the use of smaller format plates, as has been recently described 21 .
It is important to note that the time required for proteinase K digestion can vary significantly in the robot compared with benchtop ISH. We have found that a lower concentration of proteinase K in the robot system (i.e., B1 mg ml À1 compared with 10 mg ml À1 for manual ISH) often gives improved results. This will have to be individualized for each probe, but general guidelines are as follows: Scoring of chemically treated embryos. Each chemically treated well must be compared with the control wells on the same plate.
The robotic ISH results can be quite variable from day to day, so the internal controls on each plate help to account for variations in staining on that particular plate. Within a given well of eight to ten embryos, it is likely that one to three embryos will demonstrate alterations in probe staining simply because of biological or technical variability. A phenotype that occurs in more than 50% of all embryos in the well is more likely to represent a true positive result. A quantitative scoring system is very helpful, as this will naturally reveal the spectrum of phenotypic effects and subsequent follow-up can then be prioritized based on that score. dose range (i.e., 1-100 mM). For those chemicals that 'repeat' in the secondary assay, larger quantities of chemical can generally be ordered through Sigma, Alexis or similar companies. It has been generally noted by several groups involved in chemical screenings that it is not uncommon to have something 'hit' in the stock plates and then fail to repeat when a new chemical is ordered. This is usually due to an error in the identity of the compound on the stock plate, although freeze-thaw cycles and oxidation from exposure to ambient air may alter the make-up of the source compounds in a screening library. Mass spectrometry can be carried out on the initial source compound used in a screen and then compared directly with a fresh, reordered stock for chemicals that will be followed up. Periodic spot-checking of chemicals which did not produce observable effects would also be prudent for libraries that will be reused for multiple screens. Assaying for the biochemical effect of a given chemical will likely be highly specific to the developmental process or signaling pathway being assayed. Still, developing a dose-response curve across a range of concentrations for a candidate molecule may prove useful in helping to optimize follow-up assays. Identifying the lowest effective dose may help to limit toxicity and off-target effects during downstream analysis.
Finally, chemoinformatics approaches can aid in identifying compounds that are structurally related to a positive 'hit' compound 25 . Related compounds that are better characterized may provide hints as to the mechanism of action of a novel 'hit' , or can be useful to independently verify the specificity of the observed biological effect. A large number of resources exist for this purpose, and we provide links to several example web-based applications in Table 3 .
Overall timing. A typical 'bioactives' library has between 1,000-2,500 chemicals. If wild-type embryos are being used in the screen, it is entirely feasible to screen B500-1,000 chemicals per week using two to three people. Increased time and numbers of embryos may be required if screening for effects on mutant embryos (e.g., assaying for suppression of a phenotype in homozygous mutant embryos generated from heterozygous adults, in which only onefourth of embryos will be informative).
Advantages and limitations of chemical genetic screens in the zebrafish
Screening in a complete organism provides a succinct read-out of the spectrum of effects a chemical has on many cell-and tissuetypes. Using the zebrafish provides this read-out in a vertebrate organism whose size and life cycle are amenable to high throughput approaches.
The complexity and interrelatedness of developmental processes in a complete organism may cloud the distinction between direct and downstream effects of a chemical treatment. Many biochemical and signaling pathways are conserved from fish to humans, but this is not always the case. Appropriate disease models or assays may also be lacking. Finally, target identification remains a general challenge in the field of chemical genetics.
Alternatives to chemical genetic screens in the zebrafish
Cell culture-based screens or in vitro biochemical assays likely remain faster and more scalable than whole organism screens, and may be better suited for some applications. For particularly novel or poorly understood processes, classical approaches of reverse genetics (e.g., mutagenesis-based screening) may prove to be a better initial approach for establishing links to a specific gene(s).
Although we have presented an ISH-based read-out in this protocol, alternatives using fluorescence-based read-outs may be adapted for high throughput use in the future 26 .
MATERIALS

REAGENTS
. Zebrafish. Strain choice (e.g., use of a specific mutant strain) will depend on the design of a screen ! CAUTION Use of the organism will require institutional review board approval at a researcher's institution.
. Phosphate Buffered Saline (PBS) (10Â solution, Fischer Scientific, cat. no.
BP3994)
. NaCl (Fisher Scientific, cat. no. S271-1) . KCl Blocking solution 100 mg BSA, 1 ml of heat inactivated lamb serum mixed in 50 ml of PBT. Prepare fresh. For antibody incubation, add 1:5,000 (vol:vol) dilution of anti-dig antibody to blocking solution. Pre-staining buffer Mix 10 ml of 1M Tris pH 9.5, 5 ml of 1M MgCl 2 , 2 ml of 5M NaCl and 100 ml of Tween-20, and adjust to a final volume of 100 ml with double-distilled water. Prepare fresh.
Staining buffer Add 225 ml of NBT and 175 ml of BCIP to 50 ml of pre-staining buffer. Prepare fresh. On the night before collecting embryos, arrange male and female zebrafish in pairs or in groups consisting of two males and three females separated by a divider. ! CAUTION Use of zebrafish will require institutional review board approval at a researcher's institution.
Embryo collection, staging, and distribution (Day 1) TIMING 2-3 h 2| Place the mating pairs or groups in fresh water (volume will vary depending on cage size, but should be sufficient to provide B2 cm of water depth above the bottom of the mating cage) and remove the divider to allow the fish to spawn.
3| Carefully stage embryos from each collected clutch, and pool those that are within an acceptable developmental range (i.e., 10-20 min apart typically). Using a plastic transfer pipette, place B8-20 embryos into each well of a 48-well flat bottom plate. The amount of liquid placed in each well is not critical here, it will be adjusted in the next step. them to fall. Using either a custom-built or commercially available multi-well suction device placed at the top of the well, remove the liquid. Using a multi-well or repeat pipettor, add back 200 ml of embryo water (E3) into each well.
5| On the day of screening, remove 1 ml of each stock solution from the master chemical plate and place into a recipient 48-or 96-well 'transfer' plate containing 100 ml of E3 containing 1% DMSO (vol/vol) (with or without 1% penicillin/ streptomycin). Mix using either a liquid handling robot or manually. Ensure that at least 1-2 wells per 48-well plate contain only DMSO as a control. ! CAUTION Gloves should be worn when handling chemical transfer plates and treated embryo plates since any individual chemical could be potentially toxic and might be absorbed through the skin.
6| Allow the embryos, now in 200 ml of E3, to grow in the 48-well plate until they have reached the proper developmental stage for the given assay. At that point, add 100 ml of chemical from the 'transfer' plate to the wells containing the embryos in 200 ml of E3. Place the embryos back in the incubator to continue to develop until assayed.
Chemical removal, chorion removal and fixation of embryos (Day 2) (assuming B24-h chemical treatment) TIMING 1 h + overnight 7| For all of the following steps, the 48-well plate can be vertically leaned against a support to ensure embryos fall to the bottom of the well. Remove the medium containing the chemicals from the wells using the multi-channel suction device. Add 750 ml of E3 to each well to wash away any residual chemicals.
? TROUBLESHOOTING 8| Remove all 750 ml of E3 from each well, and add back 500 ml of pronase (2.5 mg ml À1 ) using a repeat pipettor. Place each plate at 28.5 1C for 10 min. Remove all of the pronase solution, add 750 ml of E3, and immediately remove with the suction device. Add 750 ml of E3 and wash for 1 min; repeat this wash a total of three to four times to ensure all bits of chorion are removed. Add 750 ml of 1Â PBT for 5 min, this is helpful to reduce sticking of the embryos in subsequent steps. m CRITICAL STEP Over-digestion with pronase can damage embryos and lead to degradation during subsequent ISH.
? TROUBLESHOOTING 9| Remove the 1Â PBT and replace with 500 ml of 4% PFA (wt/vol). Seal the plates with parafilm, and place them at 4 1C overnight. ! CAUTION PFA is toxic; avoid skin contact and inhalation of fumes. m CRITICAL STEP : Do not leave the embryos in PFA for more than 2-3 d as this may decrease the quality of the ISHs.
Dehydration (Day 3) TIMING 10-15 min + overnight 10| Remove the PFA from the wells and replace with 500 ml of 100% methanol. Seal the plates again with parafilm and place at À20 1C until ready for use. m CRITICAL STEP Embryos should be left in methanol for at least 2 h to overnight to ensure good quality ISH. ' PAUSE POINT Embryos can be left for long periods of time in 100% methanol, that is, 3-6 months.
Embryo transfer and day 1 of ISH. Day 4 (or later) TIMING 2.5 h + overnight 11| Add 50-100 ml of 1Â PBT to the methanol in each well to aid in transfer of the embryos. Next, transfer each well of embryos to the corresponding well within a 48-well mesh bottom plate using a plastic transfer pipette. m CRITICAL STEP Embryos are transferred manually between plates at this stage, so great care should be taken to avoid mixing up well numbers during this process. ? TROUBLESHOOTING 12| Carry out ISH using a Biolane HTI robot following the general methods outlined by Thisse and Thisse 15 . Prepare the appropriate volumes of solutions (see Reagent Setup above) required for day 1 of the ISH protocol. Place each 48-well mesh bottom plate in the robot and initiate the day 1 program as described in Table 4 .
13| At the conclusion of day 1 of the ISH protocol, lift the plates from the pre-hybridization solution and them place into airtight plastic containers prefilled with 50 ml of RNA probe in Hybe (+) solution, at a final concentration of 0.8-1 ng ml À1 of probe. Cover the containers tightly and place in a 70 1C hybridization oven and incubate overnight. m CRITICAL STEP Avoid leaving embryos in prehybe (Hybe +) solution for 4 2 h, as this will decrease the ISH signal intensity. m CRITICAL STEP Excessive proteinase K treatment will make the embryos fragile and less likely to survive the ISH treatment intact. ? TROUBLESHOOTING 
ANTICIPATED RESULTS
Experience from our own laboratory has indicated that generalized toxicity of any given chemical library depends strongly on the embryo stage at first exposure. A screen starting at 50% epiboly and running until 24 hpf, using a 'known bioactives' library yielded a 7% toxicity rate (R.M.W., unpublished data, see Fig. 3a -c for the appearance of embryos). In contrast, a screen that began exposure at 1-3 somites and completed at 36 hpf yielded a 3% toxicity rate 10 . The likelihood of 'false positives' is generally correlated with the strength of the phenotype on the initial screen. Scoring for gradations of ISH staining (i.e., 'darker' versus 'lighter' staining) will be more subject to technical and biological noise than assaying for complete abrogation or restoration of staining (i.e., 'present' versus 'absent'). Those chemicals that affect only half of the embryos in a given plate, and do so weakly, may be difficult to confirm in further assays. However, these should not be discarded out of hand, as this is often related to a dosing effect, so these can be tried at a higher dose. On the basis of previous experience, a 'hit' rate of B1-2% is reasonable to expect from any given screen. We have also found that independent scoring by multiple observers is useful.
Finally, we include a previously published example of the ISH-based readout (Fig. 1a-c) 14 . By noting the normal ISH staining of the HSC markers runx1 and cmyb in the control embryo (Fig. 1a) , one can see the effect of a chemical that increases (Linoleic acid) (Fig. 1b) or decreases (Celecoxib) (Fig. 1c) 
